POPE ASSET MANAGEMENT, LLC - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
POPE ASSET MANAGEMENT, LLC ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q4 2017$289,000
-1.0%
1,673,2180.0%0.19%
-0.5%
Q3 2017$292,000
-24.0%
1,673,2180.0%0.19%
-32.2%
Q2 2017$384,000
-29.7%
1,673,218
-20.4%
0.28%
-21.6%
Q1 2017$546,0000.0%2,101,6260.0%0.35%
-12.9%
Q4 2016$546,000
+21.1%
2,101,6260.0%0.40%
+11.0%
Q3 2016$451,000
+26.3%
2,101,626
-0.2%
0.36%
+22.1%
Q1 2016$357,000
+12.6%
2,104,8260.0%0.30%
+13.7%
Q4 2015$317,000
-55.7%
2,104,8260.0%0.26%
-41.3%
Q3 2015$716,000
-5.4%
2,104,8260.0%0.45%
-27.5%
Q2 2015$757,000
-47.1%
2,104,826
-50.0%
0.62%
+0.7%
Q1 2015$1,432,000
+126.6%
4,209,652
+100.0%
0.61%
+20.8%
Q4 2014$632,000
+19.7%
2,104,8260.0%0.51%
+60.6%
Q3 2014$528,000
+14.5%
2,104,826
+81.3%
0.32%
+20.7%
Q2 2014$461,000
-57.5%
1,161,282
-45.9%
0.26%
-58.0%
Q1 2014$1,084,000
+46.5%
2,146,766
-0.0%
0.62%
-39.4%
Q4 2013$740,000
+21.7%
2,147,666
-1.1%
1.02%
+18.9%
Q3 2013$608,000
+32.8%
2,171,685
-0.4%
0.86%
+13.4%
Q2 2013$458,0002,181,4490.76%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q3 2016
NameSharesValueWeighting ↓
GLENHILL ADVISORS LLC 200,000$44,0000.22%
PANAGORA ASSET MANAGEMENT INC 132,903$29,0000.00%
Citadel Advisors 60,859$13,0000.00%
JOYN Advisors, Inc. 100$00.00%
Bogart Wealth, LLC 1,000$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 25,004$5,0000.00%
Virtu Financial LLC 14,633$3,0000.00%
Renaissance Technologies 1,091,792$297,0000.00%
PARSONS CAPITAL MANAGEMENT INC/RI 10,000$2,0000.00%
UBS Group AG 9,200$2,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders